IGF-I, IGFBP-3, and IGF-I/IGFBP-3 ratio: no association with incident colorectal cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.
Max
Joshua B
JB
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Limburg
Paul J
PJ
Ogunseitan
Adeboye
A
Stolzenberg-Solomon
Rachael Z
RZ
Vierkant
Robert A
RA
Pollak
Michael J
MJ
Sellers
Thomas A
TA
Virtamo
Jarmo
J
Cerhan
James R
JR
Albanes
Demetrius
D
D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood; D015179:Colorectal Neoplasms / Q000097:blood* / Q000453:epidemiology / Q000517:prevention & control; D004797:Enzyme-Linked Immunosorbent Assay; D005387:Finland / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors; D024502:alpha-Tocopherol / Q000627:therapeutic use*; D019207:beta Carotene / Q000627:therapeutic use*
D014408:Biomarkers, Tumor; D018972:Insulin-Like Growth Factor Binding Protein 3; D019207:beta Carotene; D007334:Insulin-Like Growth Factor I; D024502:alpha-Tocopherol